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ChaperoneThe missense mutation pG46S in the regulatory (R) domain of human phenylalanine hydroxylase (hPAH),
associated with a severe form of phenylketonuria, generates a misfolded protein which is rapidly degraded on
expression in HEK293 cells. When overexpressed as a MBP-G46S fusion protein, soluble and fully active
tetrameric/dimeric forms are assembled and recovered in a metastable conformational state. When MBP is
cleaved off, G46S undergoes a conformational change and self-associates with a lag phase and an autocatalytic
growth phase (tetramers≫dimers), as determined by light scattering. The self-association is controlled by
pH, ionic strength, temperature, protein concentration and the phosphorylation state of Ser16; the net charge
of the protein being a main modulator of the process. A superstoichiometric amount of WT dimers revealed a
2-fold enhancement of the rate of G46S dimer self-association. Electron microscopy demonstrates the
formation of higher-order oligomers and linear polymers of variable length, partly as a branching network,
and partly as individual long and twisted ﬁbrils (diameter ~145–300 Å). The heat-shock proteins Hsp70/
Hsp40, Hsp90 and a proposed pharmacological PAH chaperone (3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-
1,2-dihydroisoquinolin-1-one) partly inhibit the self-association process. Our data indicate that the G46S
mutation results in a N-terminal extension of α-helix 1 which perturbs the wild-type α–β sandwich motif in
the R-domain and promotes new intermolecular contacts, self-association and non-amyloid ﬁbril formation.
Themetastable conformational state of G46S as aMBP fusion protein, and its self-association propensity when
released from MBP, may represent a model system for the study of other hPAH missense mutations
characterized by misfolded proteins.ylase; rPAH, rat phenylalanine
ine; BH4, (6R)-L-erythro-5,6,7,8-
; MBP, maltose binding protein;
, tetramer; DM, dimer; ANS, 8-
xide; EM, electron microscopy
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The human inborn error of metabolism phenylketonuria (PKU;
OMIM# 261600) is caused by a dysfunction of the liver enzyme
phenylalanine hydroxylase (hPAH; EC 1.14.16.1), inherited in an
autosomal recessive fashion. At presentN500 disease causingmutations
havebeen identiﬁed in thehuman PAHgene (seePAHMutationAnalysis
Consortium database: http://www.pahdb.mcgill.ca/) [1]. Most of them
are associated with PKU, and a smaller number has been identiﬁed
among non-PKU hyperphenylalaninemia (HPA) patients. The current
spectrum of alleged PKU/HPA mutations consists of ~60% missense
substitutions, ~13% splice variants, ~13% deletions, ~6% nonsense
(termination) mutations, and a few insertions, representing a broadspectrum of clinical, metabolic and enzymatic phenotypes [2]. Expres-
sion analyses of ~100 missense mutations in complementary in vitro
systems (for review, see the PAH Mutation Analysis Consortium
database) [1] have identiﬁed at least three main groups of enzymatic
phenotypes which differ in their kinetic behavior and/or stability [3,4],
i.e. (i) structurally stable mutations with altered kinetic properties, e.g.
mutations at residues involved in substrate (L-phenylalanine, L-Phe) or
the pterin cofactor ((6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, BH4)
binding; (ii)mutationswithnormal or almostnormalkinetic properties,
but reduced stability both in vitro and in vivo; and (iii) mutations
affecting both kinetic and stability properties of the enzyme.
Since a majority of the mutations results in enzyme forms with a
propensity to self-associate when expressed as recombinant proteins in
E. coli or in an in vitro transcription–translation system, PKU is often
considered as a protein misfolding disease [5]. These mutations are
located in different regions of the three-domain structure [4,6–9], and
the mechanism of self-association may therefore have a variable
structural basis. When overexpressed in E. coli several misfolding
mutations result in both soluble and insoluble “aggregates”, even when
expressed and puriﬁed as MBP fusion proteins. Although MBP has been
shown to have a chaperone like effect [10,11], the soluble mutant
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However, in some mutations, e.g. the missense mutation pG46S in the
regulatory (R) domain, the expressed protein is assembled and
recovered as stable tetrameric/dimeric forms, in addition to some
soluble higher-order oligomers [12]. The MBP-G46S-hPAH tetramer is
characterized by a near normal catalytic efﬁciency, but when the
tetramer is cleaved by the restriction protease factor Xa, the G46S
tetramer is destabilized and self-associates [12]. When expressed in
eukaryotic cells as a non-fusion protein the enzyme is unstable and is
rapidly degraded [12], thus explaining the severe PKU phenotype.
However, the molecular mechanism of the self-association and the
structural properties of the higher-order oligomers remain to be
determined.
In the present study, the pG46S mutation was carefully analyzed.
This mutation belongs to the second group of enzymatic phenotypes
previously deﬁned, with reduced stability both in vitro and in vivo that
results in a severe form of PKU [12]. This group represents a large
proportion of the PKU mutations, with a loss-of-function pathogenesis
due to reduce stability [13]. The mutation pG46S is also located in the
regulatory domain of hPAH, and there is growing evidence that the R-
domain of hPAH is largely involved in the instability of hPAH mutant
proteins [9]. Therefore, the recombinantWT-hPAH and the G46S-hPAH
mutant form were isolated as MBP-(pep)Xa-PAH fusion proteins with
the goal to: (i) characterize the self-association process of G46S-hPAH
induced in vitro by factor Xa cleavage and how the solvent conditions
affect its propensity to self-associate; (ii) examine the effect of
substrates (L-Phe andBH4), phosphorylation of Ser16 (Ser16 is, together
with substrate and cofactor, one of the main regulators of hPAH
function, involved in the activation of the enzyme [14] and causing
conformational changes in the regulatory domain [15,16]) and
molecular/pharmacological/chemical chaperones on the propensity to
self-associate; (iii) investigate if the self-association results in the
formation of any stable polymeric structures such asﬁbrils, and (iv) gain
some insight into the molecular mechanism by which such structures
are formed. To answer these questions,weused a combined approachof
real-time light-scattering, thioﬂavin-T and ANS ﬂuorescence and
structural analyses by electron microscopy (EM). Additionally, comple-
mentary studies on a MBP fusion protein with the regulatory domain,
comprising residues 2–120, were performed on the WT and G46S
mutant form.
2. Material and methods
2.1. Materials
TB1 cells, the prokaryotic expression vector pMAL-c2/pMAL-hPAH
and the amylose resin were obtained from New England Biolabs (USA).
The restriction protease factor Xa was obtained from Protein Engineer-
ing Technology ApS (Aarhus, Denmark). The catalytic C-subunit of
cAMP-dependent protein kinase (PKA)was from Biafﬁn GmBH& Co KG
(Kassel, Germany). SDS molecular mass standard (low Mr range) was
delivered byBio-Rad. Thepterin cofactor tetrahydrobiopterin (BH4)was
obtained from Schircks Laboratories (Jona, Switzerland) and glycerol,
trimethylamine N-oxide (TMAO) and (−)-epigallocatechin gallate
(EGCG) were from Sigma-Aldrich (St. Louis, MO, USA). 3-amino-2-
benzyl-7-nitro-4-(2-quinolyl)-1,2-dihydroisoquinolin-1-one was pur-
chased from Maybridge (Tintagel, Cornwall, UK). The recombinant
humanmolecular chaperones Hsp40 (catalog number SPP-400), Hsp70
(catalog number ESP-555) and Hsp90 (catalog number SPP-776) were
provided by Assay Designs (Ann Arbor, MI, USA).
2.2. Site-speciﬁc mutagenesis
The WT regulatory domain (WT-hPAH (2–120)) and the mutant
G46S regulatory domain (G46S-hPAH (2–120)) were obtained by
introducing a stop signal in codon 121 of hPAH, by site-directedmutagenesis (QuikChangeR II, Stratagene), using the pMAL-WT-hPAH
vector [17] and pMAL-G46S-hPAH vector [12] as template, respectively.
Primers 5′-GACACAGTGCCCTGGTAACCAAGAACCATTCAAGAGC-3′ (for-
ward) and 5′-GCTCTTGAATGGTTCTTGGTTACCAGGGCACTGTGTC-3′
(reverse) used for mutagenesis were provided by Eurogentec, Seraing,
Belgium (the mismatch nucleotides are shown in bold type). The
authenticity of the mutagenesis was veriﬁed by DNA sequencing as
described previously [12].
2.3. Expression and isolation of fusion proteins
Expression of both the WT and the mutated form G46S of hPAH
and the R-domain of hPAH (residues 2–120) was performed in E. coli
as fusion proteins (MBP-(pep)Xa-hPAH) [17]. The bacteria were
grown at 37 °C and the induction of hPAH by 1 mM isopropyl-thio-
β-D-galactoside (IPTG) was performed for 24 h at 28 °C. The fusion
proteins were puriﬁed by afﬁnity chromatography (amylose resin) and
centrifuged in a TL-100 Ultracentrifuge (Beckman, USA) for 20 min at
50,000 g before size-exclusion chromatography (SEC) as described [17].
SEC was performed at 4 °C using a HiLoad Superdex 200 HR column
(1.6 cm×60 cm) prepacked from Amersham Biosciences (GE Health-
care, Uppsala, Sweden). Themobile phase consisted of 20 mMNa-Hepes
and 0.2 M NaCl, pH 7.0 and the ﬂow rate was 0.38 ml min−1. The
tetrameric/dimeric hPAHfusionproteins and theR-domain of hPAHalso
as a fusion protein were collected and concentrated by Centriplus 30
ﬁlter (Amicon, MA, USA). The concentration of puriﬁed fusion proteins
was measured by the absorption coefﬁcient A280 (1 mgml−1 cm−1)=
1.63 [17] for the full-length enzymes andA280 (1 mgml−1 cm−1)=1.34
for the truncated form hPAH (2–120). A colorimetric method [18] was
also used in some cases tomeasure enzyme concentrations, with bovine
serum albumin as the standard.
T427P-hPAH [19] and ΔC24-hPAH [20] were expressed as fusion
proteins with MBP in E. coli and isolated essentially as the G46S
mutant protein, except that before SEC the proteins were cleaved for
4 h at 4 °C by factor Xa protease, using a protease to substrate ratio of
1:200 (by mass) to remove the MBP partner.
2.4. Phosphorylation of hPAH fusion protein
The phosphorylation of the fusion protein (tetrameric form) was
performed in a reactionmixture containing 0.1 mMethylene glycol bis-
(α-amino ether)-N,N,N′N′-tetraacetic acid, 0.03 mM EDTA, 1 mM DTT,
10 mM MgAc, 60 μM ATP in 15 mM Na-Hepes, pH 7.0, at 30 °C for 1 h
[21]. The enzyme concentrations were 20 μM (hPAH) and 100 nM
(catalytic subunit) of PKA. The degree of phosphorylationwasmeasured
by the electrophoreticmobility shift [6]. The non-phosphorylated fusion
protein controlwasobtainedby incubating theenzyme in theabsenceof
added PKA catalytic subunit, under otherwise identical conditions.
2.5. Cleavage of MBP-hPAH fusion proteins and assay of self-association
by light scattering
In order to study the time-course for the cleavage of the tetrameric
and dimeric MBP-hPAH fusion proteins and the self-association of the
released enzyme, the fusion proteins were incubated in a medium
containing 20 mM Na-Hepes, 0.1 M NaCl, pH 7.0 at 25 °C, except when
stated otherwise. Before assay the tetrameric or dimeric fusion proteins
were subjected to high-speed ultracentrifugation at 210,000 g for
15 min at 4 °C. In the standard assay the concentration of the fusion
protein was 0.74 mgml−1 and the concentration of factor Xa was
adjusted to give a ﬁnal ratio (by weight) of 1:150 relative to the fusion
protein. Parameters as pH, neutral salt concentration, temperature,
protein concentration and the presence of substrates (L-Phe and BH4)
varied in different experiments as described in the Results section. Self-
association of the factor Xa released enzyme was followed in real-time
by light scattering, as measured by the increase in apparent absorbance
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Spectrophotometer with a Peltier temperature control unit. The change
in light scattering was expressed as ΔA′350 by subtracting the
background absorbance in the absence of added factor Xa. ΔA′350/Δt is
the rate of formationof higher-order oligomers/polymers obtained from
the slope of the linear growth phase of each light scattering curve. For
every self-association experiment a parallel time-course cleavage
analysis was conducted to rule out any change in the cleavage rate of
the fusion protein.
2.6. SDS-PAGE analyses
SDS-PAGE analyses were performed in a 10% (w/v) polyacryl-
amide gel [22]. The gels were stained by Coomassie Brilliant Blue R-
250, scanned using VersaDoc 4000 (Bio-Rad) and quantiﬁcation of the
protein bands was obtained by using the Quantity One 1-D Analysis
Software (Bio-Rad Laboratories, Hercules, CA, USA).
2.7. Cleavage of G46S-hPAH fusion protein in the presence of chaperones
In order to study the inﬂuence of chaperones on the self-association
process following cleavage of the mutant enzyme, tetrameric MBP-
G46S-hPAH and chaperone were added (together with the factor Xa
protease) at a variable molar ratio as described in Results. The
experimental conditions were the same as in the cleavage experiments
without chaperone, except in the caseof thepharmacological chaperone
thatwas dissolved in DMSO and used at a ﬁnal concentration of 100 μM
and 0.83% DMSO. In this case controls were included with 0.83% DMSO.
2.8. Negative staining electron microscopy
For negative staining EM of unpolymerized and polymerized G46S-
hPAH Formvar-coated 200 mesh nickel grids (Electron Microscopy
Sciences, Fort Washington, USA) were used. The grids were further
coated with carbon, stored dust-free in Petri dishes kept at low
humidity, and glow-discharged for 15 s prior to use. Negative staining
was carried out by ﬁrst applying 5 μl of a protein solution on the
specimen grid. Following absorption for 60 s, the sample drop was
removed by blotting with ﬁlter paper and the grid was stained twice
with 2% aqueous uranyl acetate. After application, the ﬁrst drop (10 μl)
was blotted off immediately, whereafter a fresh drop of the stain was
added to the grid for 15 s. After ﬁnal blotting and drying, the specimens
were observed in a Jeol 1230 Electron Microscope operated at 80 kV.
2.9. Thioﬂavin-T ﬂuorescence assay
The assay was performed according to a standard protocol [23].
Brieﬂy, the thioﬂavin-T (ThT, Sigma-Aldrich)measurementsweremade
by taking reaction aliquots and diluting them to 1.3 μMhPAH in 20 mM
Na-Hepes, 0.1 M NaCl, pH 7.0 containing 20 μM ThT. Immediately
following sample preparation the ﬂuorescence was measured in a
Perkin-Elmer LS-50B instrument (Perkin-Elmer, Waltham, MA, USA) at
25 °C (constant temperature cell holder) using an excitation of 440 nm
andemission of 482 nm,with slitwidths for excitation and emissionof 3
and 7 nm, respectively, andby averaging four scans. The reportedvalues
were correctedby subtracting thebackgroundﬂuorescence of ThT in the
absence of protein oligomers and controls with the protein oligomers in
the absence of ThT (light scattering).
2.10. ANS ﬂuorescence assay
Binding of 8-anilino-1-naphthalenesulfonic acid (ANS, Sigma-
Aldrich) was performed as described by Aukrust et al. [24]. Brieﬂy,
1.3 μMhPAHwas incubatedwith 60 μMANS in 20 mMNa-Hepes, 0.1 M
NaCl, pH7.0 at roomtemperature for 5 min in thedark. Theﬂuorescence
emission spectra were recorded between 400 and 600 nm (6 nm slitwidth) at 25 °C using an excitation wavelength of 385 nm (6 nm slit
width) on a Perkin-Elmer LS-50B luminescence spectrometer and by
averaging four scans.
2.11. Assay of hPAH activity
The hPAH activity was assayed at 25 °C in a standard reaction
mixture containing a 0.4 μM subunit (unless otherwise stated)
of tetrameric WT or G46S mutant fusion protein forms of hPAH, 1 mM
L-Phe, 0.5 mg ml−1 bovine serum albumin, 5 mM dithiothreitol,
0.1 mgml−1 catalase, 100 μM ferrous ammonium sulfate in 100 mM
Na-Hepes, pH 7.0 [17]. After preincubation (5 min) with L-Phe the
reaction was started by adding 75 μM (unless stated otherwise) BH4 to
the reaction mixture. The amount of L-Tyr formed after 1 min was
measured by high pressure liquid chromatography and ﬂuorimetric
detection [25]. The steady-state kinetic datawere analyzed by nonlinear
regression analysis using the SigmaPlot® Technical Graphing Software
and themodiﬁedHill equationof LiCata andAllewel [26] for cooperative
substrate binding as well as substrate inhibition [27]. In some
experiments, 1 mM L-Phe was added either at the start of the
preincubation period or together with 75 μM BH4 at the initiation of
the hydroxylation reaction. In this case a 3 min time-course was then
followed in order to study the effect of preincubation with L-Phe on the
speciﬁc activity.
2.12. Computational analysis
An estimation of the free energy of unfolding of the mutant protein
was predicted using the CUPSAT server (http://cupsat.tu-bs.de/) [28]
and the free energy of folding was predicted using the Concoord/PBSA
server (http://ccpbsa.bioinformatik.uni-saarland.de/ccpbsa/) [29]. In
order to evaluate the effect on G46S mutation on the secondary
structure of the hPAH protein an algorithm based on helix–coil
transition theory, AGADIR, was used to predict helical propensity
(http://agadir.crg.es/) [30]. To identify the location of hinges in PAH we
subjected the apo-rPAH crystal structure (PDB ID: 2PHM) to further
analysis using the HingeMaster software program that predicts the
hinge location in a protein by integrating existing hinge predictors
(TLSMD, StoneHinge, FlexOracle and HingeSeq) with a family of novel
hinge predictors based on grouping residues with correlated normal
mode motions (http://molmovdb.org/cgi-bin/submit-ﬂexoracle.cgi)
[31].
2.13. Statistical analyses
Data obtained from independent measurements are presented as
mean±SD and Student's t-test was conducted for statistic analysis of
quantitative data (Pb0.01 was considered signiﬁcant).
3. Results
3.1. Structural effects of the G46S mutation
The~50 kDamonomer ofWTmammalianPAHassembles in vivoand
on overexpression in bacteria to form tetramers (TMs) and dimers
(DMs). Atomic resolution structures of hPAH and rPAH have revealed
that the monomer consists of three structural and functional domains,
i.e. a regulatory (R), a catalytic (C) and a tetramerization (T) domain
[32–34]. On the basis of the 3D structures of the C–T domains of hPAH
and the R–C domains of rPAH a composite full-length model has been
assembled for the PAH tetramer [8] (Fig. 1A and B). It is organized as an
asymmetric dimer of dimers, and the model has the approximate
dimensions of 85 Å×100 Å×75 Å. The R-domain has an α–β sandwich
(βαββαβ) motif composed of a four-stranded antiparallel β-sheet
ﬂanked on one side by two short α-helices and the other side by the C-
domain (Fig. 1C). Using the HingeMaster software program [31] (see
Fig. 1. 3D structure of PAH and the localization/interactions of the G46 residue in the N-terminal regulatory domain. (A) Structure of a composite model of full-length tetrameric
hPAH. Cα-trace ribbon of the model created by combining the regulatory/catalytic domain crystal structure of rPAH (PDB ID: 1PHZ) and the catalytic/tetramerization domain
structure of hPAH (PDB ID: 2PAH). Each monomer is colored separately, with the lightest color representing the regulatory domain (R) and the darkest color representing the
tetramerization domain. (B) Side view 90° rotation from the view in A, with the position of the four regulatory domains indicated by a R. (C) Ribbon representation of the regulatory/
catalytic domain crystal structure of rPAH in the monomeric form with the regulatory domain shown in green, the catalytic domain in red and G46 in stick model (pointed arrow).
(D) Close-up of the location of G46 in the regulatory domain of rPAH, at the end of the loop between β-strand 1 and α-helix 1, where it H-bonds to K50. The Cα-atom trace is shown
in green ribbon, with the relevant residues in stick model and water molecules as red spheres. The ﬁgures were created using MOLSCRIPT [76] (A and B) and PyMOL, version 1.1
(DeLano Scientiﬁc) [77] (C and D).
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domain structurearound the interdomain residues 118–119andaround
the intradomain residues 26–27 (Fig. 2A).
The residue G46 is positioned at the entry of α-helix 1 (A47–E57)
in a ﬁve residue (L41–G46) loop structure (loop 1), with a relatively
low crystallographic B-factor (Fig. 2B), linking β-strand 1 and α-helix
1 (Fig. 1D), and is stabilized by H-bonds and a salt-bridge (K42–E44)
(Fig. 1D). The α-helix 1 is stabilized at the C-terminal end by forming a
hydrophobic interphase with α-helix 2 (not shown). Using the
coordinates of the R–C domains (PDB ID: 1PHZ) and two structure-
based methods for the estimation of the free energy of unfolding [28]
and folding [29] of mutant proteins, substitutions of G46 with any
amino acid were found to be destabilizing, and for the G46S mutation
the folding free energy was calculated to ΔΔG=4.1 kcal mol−1 with a
major electrostatic contribution (ΔΔGes=4.7 kcal mol−1). Since Gly
is known to have a large destabilizing effect on α-helices [35],
whereas a substituted Ser and the preceding residues (V45, E44, E43,
K42 and L41) in loop 1 have all a relatively high α-helix-forming
propensity [35], the G46 substitution is predicted to promote a N-terminal extension of α-helix 1 by four residues or one turn using the
AGADIR algorithm [30] (Fig. 2C).
3.2. Expression and isolation of the MBP fusion proteins
On expression of WT and the mutant form G46S as fusion proteins
(MBP-(pep)Xa-hPAH) the proteins were obtained in high yields and
separated into their oligomeric forms by SEC (Fig. 3A and B). The
chromatogram of both forms revealed a comparable elution pattern in
which peak 1 represented higher-order oligomeric forms (eluted at or
near the void volume), and peak 3 and peak 4 represented the TM and
DM forms, respectively [12,17].
3.3. Catalytic properties of MBP-WT-hPAH and MBP-G46S-hPAH fusion
proteins
Determination of the steady-state catalytic properties of the
tetrameric MBP-G46S-hPAH fusion protein revealed that it has a
higher speciﬁc activity than the WT protein, and a slightly higher
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Fig. 2. Structural properties of the regulatory domain. (A) Combined hinge prediction
scores of the R–C domain structure in the non-phosphorylated form of rPAH (PDB ID:
2PHM) using the HingeMaster server [31] as a function of amino acid residue number. A
similar score proﬁle was obtained for the phosphorylated form (PDB ID: 1PHZ). (B) The
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[S]0.5=106±2 μM for MBP-WT-hPAH) (Table 1). The afﬁnity for the
cofactor BH4 was unaffected. The mutant fusion protein revealed a
low kinetic cooperativity with respect to L-Phe (nH=1.2±0.1) and
was already in an activated conformational state. Both proteins
showed an inhibition at higher substrate concentrations.3.4. Cleavage of the MBP fusion proteins
In the standard assay conditions the cleavage reaction was similar
for the tetrameric WT (not shown) and the mutant fusion protein
(Fig. 4A), with t1/2 (time at 50% cleavage) of ~11 min. The half-time
and the end point of the cleavage reaction varied to some extent with
the solvent conditions, notably with the ionic strength (Supplemen-
tary Fig. S1A) and the temperature (Supplementary Fig. S1B).
3.5. Self-association of tetrameric and dimeric forms of G46S-hPAH
At the selected standard assay conditions (pH 7.0, 0.1 M NaCl and
25 °C) the cleavage of the MBP-WT-hPAH tetramer (0.74 mg ml−1)
did not result in any change in light scattering (Fig. 4B). By contrast,
the G46S-hPAH mutant form revealed a propensity to self-associate
(Fig. 4B). A sigmoidal time-course was observed for the increase in
light scattering with three relatively distinct phases, i.e. a delay period
(lag phase), a growth phase of increasing light scattering (ΔA′350/Δt
(AU min−1)=0.026±0.003) and a ﬁnal phase with a decrease in
light scattering. In the absence of added factor Xa no change in light
scattering of theMBP-G46S-hPAH fusion protein was observedwithin
the time-scale of 3 h. A comparison of the TM and DM mutant fusion
proteins (Fig. 7A) revealed that the DM displayed a similar lag phase
but a 2-fold lower ΔA′350/Δt value than the TM (at equal protein
concentration) at pH 7.0.
3.6. Effects of pH and ionic strength
WT-hPAH and the R-domain (residues 1–120) have theoretical pIs
of ~pH 6.2 and ~pH 6.1, respectively. Whereas no signiﬁcant
difference was observed in the cleavage rate of the fusion protein in
the pH interval of 6.4 to 8.0 (Supplementary Fig. S2A), a large effect of
pHwas observed on the self-association (Fig. 5). Thus, by lowering the
pH towards the pI, the lag phase was reduced and the ΔA′350/Δt value
greatly increased. At pH 8.0, with a theoretical net charge of ~−9.2 no
measurable ΔA′350/Δt value was observed within the time-scale of
3 h.
The ionic strength (range 0.1 M and 0.4 M NaCl) has a certain effect
on the rate of cleavage of MBP-G46S-hPAH (Supplementary Fig. S1A),
but a more dramatic effect on the lag phase and the ΔA′350/Δt value of
G46S-hPAH self-association (Table 2), demonstrating the importance of
the global charge in the process.
3.7. Effect of temperature and protein concentration
Whereas the rate of the cleavage was only slightly slower at 15 °C
(t1/2 of 13.3 min) than at 25 °C (t1/2 of 11.3 min) (Supplementary Fig.
S1B), the self-association was largely affected by the reaction
temperature. Thus, on increasing the temperature the lag phase
decreases and the rate of self-association (ΔA′350/Δt) increases
(Table 2) with an apparent activation energy (Ea) of 134 kJ mol−1.
When the cleavage reaction was followed at the standard assay
conditions, but with variable concentrations of fusion protein at a
constant ratio of factor Xa:G46S-hPAH=1:150 (by weight), the half-
time was almost the same in the range of 0.37 to 0.74 mg ml−1
(Supplementary Fig. S2B). A more pronounced effect was observed on
the lag phase and the rate of self-association (ΔA′350/Δt) (Table 2).
3.8. The effect of substrates and phosphorylation of Ser16
The binding of L-Phe or the pterin cofactor BH4 at the active site
triggers global conformational changes in the WT tetramer, including
the R-domain [8]. Here, however, we observed no signiﬁcant modula-
tion of the self-association of G46S-hPAH in the presence of 75 μMBH4,
whereas 1 mM L-Phe slightly reduced the lag phase and increased the
ΔA′350/Δt value (Table 2).When the fusion proteinwas phosphorylated
Fig. 3. Size-exclusion chromatography of WT-hPAH and the mutant G46S-hPAH. (A) The chromatogram of WT-hPAH with 4 main peaks, where peak 1 represents higher-order
oligomeric forms (eluted in the void volume), peak 2 a presumably octameric form, peak 3 the tetramer (~365 kDa) and peak 4 the dimer (~209 kDa). (B) The chromatogram of the
mutant form G46S-hPAH where the broad peak 1 represents higher-order oligomeric forms, peak 3 and 4 the tetramer and dimer, respectively. The apparent molecular mass of the
enzyme forms were estimated using the elution position of standard molecular mass markers as a reference (not shown). The two dashed lines indicate the collected tetramers used
in further experiments. The proteins were expressed as MBP fusion proteins in E. coli under identical expression conditions (24 h, 28 °C). The chromatography was performed on a
HiLoad Superdex 200 HR column (1.6 cm×60 cm), equilibrated and eluted with 20 mMNa-Hepes, 0.2 MNaCl, pH 7.0 at a ﬂow rate of 0.38 ml ml−1 at 4 °C; detection was at 280 nm.
The inset in panels A and B represent the SDS-PAGE analyses demonstrating the purity of the tetrameric fusion proteins. LaneM, low-molecular-mass standard (106.5, 97.6, 50.2, 36.9
and 28.9 kDa); lane 3, the respective tetrameric form enzymes (peak 3) of the size-exclusion chromatography.
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inhibited, with a longer lag phase and a decreased ΔA′350/Δt value
(Fig. 6A). The time-courses for the cleavage of the phosphorylated and
non-phosphorylated MBP-G46S-hPAH were essentially identical (Sup-
plementary Fig. S2C), and the substrates were without effect on the
cleavage of MBP-G46S-hPAH (Supplementary Fig. S2D).
3.9. Effects of heat-shock proteins
Molecular chaperones facilitate the proper folding of many newly
synthesized proteins as well as rescue proteins that are misfolded, e.g.
due to mutations. Chaperone proteins also exhibit the unique property
to inhibit self-association of certain client proteins [36]. From Fig. 6 it is
seen that the Hsp70/Hsp40 chaperone system inhibits the self-
association of G46S-hPAH in a dose-dependent manner. At the lowest
molar ratio (1:20) of Hsp70/Hsp40 there is no effect on the ΔA′350/Δt
value, whereas at the higher ratio (1:2) the heat-shock proteins
markedly prolong the lag phase and decrease the ΔA′350/Δt value
(Fig. 6B). A similar effect was observed for Hsp90 at a molar ratio of 1:2
(Fig. 6C). In control experiments with ovalbumin, no such effects were
observed. Moreover, for both chaperones the addition of ATP did not
further enhance the modulatory effects observed in the absence of
nucleotide (data not shown). The chaperones did not contain cleavage
sites for factor Xa restriction protease and were without effect on the
cleavage of MBP-G46S-hPAH (Supplementary Fig. S2E).Table 1
Kinetic properties of tetrameric wild-type hPAH (MBP-WT-hPAH) and G46S-hPAH (MBP-G
BH4 L-Phe
Vmax
(nmol Tyr min−1 mg−1)
Km
(μM)
Vmax
(nmol Tyr min−1 mg−1)
[S]0.5
(μM)
MBP-WT-hPAH 3346±151 43±5 2360±33 106±2
MBP-G46S-hPAH 4227±187 42±5 3677±104 74±5
The catalytic activity was measured as described in the Materials and methods section at 25
variable). [S]0.5 represents the L-Phe concentration at half-maximal activity and kcat/[S]0.5 the
molecular mass of 94 kDa.3.10. Effects of pharmacological and chemical chaperones
The pterin cofactor BH4 has been shown to increase the stability
versus limited proteolysis by trypsin of WT-hPAH [37], as well as of a
number of PKU mutant proteins in vitro, and to make them less
vulnerable to degradation pathways when expressed in cells [38].
Since the structural basis of the stabilizing effect is quite well
understood [37–39] the cofactor is currently used as a pharmacolog-
ical chaperone in the treatment of a subgroup of PKU/HPA patients
[40]. However, as seen from Table 2, BH4 did not have any protective
effect on the self-association of G46S-hPAH.
A recent screening of over 1000 pharmacological agents has
identiﬁed two small-molecule binders (3-amino-2-benzyl-7-nitro-4-
(2-quinolyl)-1,2-dihydroisoquinolin-1-one and 5,6-dimethyl-3-(4-
methyl-2-pyridinyl)-2-thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4
(1H)-one) as potential therapeutic agents to treat PKU [41]. Here we
have found that only 3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-1,2-
dihydroisoquinolin-1-one, at a comparable concentration (100 μM),
partly inhibits the in vitro self-association of G46S-hPAH (Fig. 6D).
The use of osmolytes can produce a chemical chaperoning effect in
vitro and thus be able to rescue folding defects in proteins involved in
conformational disorders [42,43]. In this study we have tested
glycerol, trimethylamine N-oxide (TMAO) and (−)-epigallocatechin
gallate (EGCG), but only glycerol showed a protective effect, while the
other two compounds promoted the self-association (Table 2). The46S-hPAH) fusion proteins.
kcat/[S]0.5
(μM−1 min−1)
nH Vi
(nmol Tyr min−1 mg−1)
Ki
(μM)
Fold activation
R(ν+L-Phe/ν -L-Phe)
2.09 2.5±0.1 1072±218 3190±644 3.9
4.67 1.2±0.1 1521±131 1911±241 1.1
°C; the substrate concentrations were 1 mM L-Phe (BH4 variable) and 75 μM BH4 (L-Phe
“catalytic efﬁciency”. The “catalytic efﬁciency”was calculated on the basis of a subunit
Fig. 4. The self-association of tetrameric G46S-hPAH following cleavage of theMBP fusion
protein by factor Xa. (A) Time-course for the cleavage of tetrameric MBP-G46S-hPAH by
the restriction protease factor Xa. The cleavage was performed at standard assay
conditions (0.74 mg ml−1 fusion protein, 5.0 μg ml−1 factor Xa, 20 mM Na-Hepes, 0.1 M
NaCl, pH7.0 and 25 °C). 50% cleavagewas obtained at ~11 min (t1/2). The datawasﬁtted to
a single exponential decay curve. The inset represents a 10% SDS-PAGE analysis of the
cleavage reaction. Aliquots (4 μg protein) were withdrawn at 0, 10, 20 and 30 min (lanes
2–5, respectively), and at 1, 1.30, 2, 2.30 and 3 h (lanes 6–10, respectively). Lane 1, low-
molecular-mass marker (104.4, 83.2, 49.3, 36.9 and 28.9 kDa). (B) Self-association of the
releasedenzymewas followed in real-time by light scattering, asmeasuredby the increase
in the apparent absorbance at 350 nm (A′350=log [Io/(Ip+f ∙ Id)]) using an Agilent 8453
Diode Array Spectrophotometer. The change in light scatteringwas expressed asΔA′350 by
subtracting the background absorbance in the absence of the added factor Xa. The data
points correspond toG46S-hPAH fusionprotein following cleavageby factorXa (●), and in
the absence of factor Xa (○);WT-hPAH fusion protein following cleavage by factor Xa (▲)
and in theabsenceof factorXa (Δ). Somedatapointswereomitted for clarity. The reactions
were performed at standard assay conditions. Error bars represent mean±SD, n=3–5
independent experiments. The inset represents SDS-PAGE analysis of the G46S-hPAH
fusion protein at t=0 (lane 2), and following its cleavage by factor Xa at t=180 min (lane
3). The reactionmixture (after 180 min)was subjected to ultracentrifugation at 200,000 g
and both the supernatant (lane 4) and pellet (lane 5)were recovered and analyzed by 10%
SDS-PAGE. Lane 1, low-molecular-mass marker (104.4, 83.2, 49.3, 36.9 and 28.9 kDa).
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Fig. 5. The effect of pH. The effect of pH on the lag phase (●) and the rate of self-
association (ΔA′350/Δt) (▲) of G46S-hPAH tetramer at otherwise standard assay
conditions. Error bars represent mean±SD.
Table 2
The effect of solvent conditions, protein concentration, substrates and chemical
chaperones on the self-association of tetrameric G46S-hPAH.
Lag phase
(min)
ΔA′350/Δta
(AU min−1)
(ΔA′350)max
(AU)
[NaCl]
(mM)
100 41.9±2.1 0.026±0.003 1.24±0.04
200 112.1±3.3 0.007±0.001 0.49±0.09
400 118.5±2.1 0.000±0.000 0.03±0.01
Temperature
(°C)
15 87.5±8.0 0.006±0.002 0.49±0.17
25 41.9±2.1 0.026±0.003 1.24±0.04
[G46S-hPAH fusion protein]
(mg ml−1)
0.37 79.5b 0.014b 0.85b
0.49 44.3b 0.017b 0.91b
0.74 41.9±2.1 0.026±0.003 1.24±0.04
L-Phe
(mM)
0 41.9±2.1 0.026±0.003 1.24±0.04
1 38.7±4.3 0.035±0.009 1.30±0.14
BH4
(μM)
0 41.9±2.1 0.026±0.003 1.24±0.04
75 45.7±4.0 0.021±0.008 1.22±0.15
Glycerol
(%)
0 41.9±2.1 0.026±0.003 1.24±0.04
1 49.6±3.3 0.020±0.004 1.13±0.16
2.5 55.9±1.3 0.011±0.001 0.84±0.04
5 95.3±5.1 0.004±0.001 0.33±0.08
Trimethylamine N-oxide 0 41.9±2.1 0.026±0.003 1.24±0.04
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tested were without effect on the cleavage of MBP-G46S-hPAH
(Supplementary Fig. S2D and F).(TMAO)
(mM)
5 39.8b 0.032b 1.35b
150 31.8b 0.039b 1.59b
250 30.5±3.5 0.048±0.008 1.68±0.19
(−)-Epigallocatechin gallate
(EGCG)
(G46S-hPAH:EGCG)
1:0 41.9±2.1 0.026±0.003 1.24±0.04
1:0.1 28.6±1.3 0.038±0.001 1.27±0.01
1:1 23.3±2.4 0.113±0.014 2.37±0.14
a ΔA′350/Δt is the rate of formation of higher-order oligomers/polymers as obtained
from the slope of the linear growth phase of each light scattering curve. Values are
shown as mean±SD (n=3–5).
b SD not determined.3.11. Effects ofWT-hPAHdimer andΔC24-hPAHdimer on the self-association
of G46S-hPAH dimer
Since the G46S-hPAH tetramer self-associates to higher-order
oligomers at a 2-fold higher rate than the dimer (Fig. 7A), it was of
interest to see if a molar excess of the WT-hPAH dimer, which does not
self-associate beyond the tetramer (data not shown), has any effect on theself-association of G46S-hPAH dimer. From Fig. 7B it is seen that theWT-
hPAHdimer at a 5-foldmolar excessmarkedly shortens the lag phase and
increases the ΔA′350/Δt value about 2-fold, presumably by promoting the
formation of G46S-WTheterotetramers (see Discussion). By contrast, a 5-
fold molar excess of the truncated ΔC24-hPAH dimer, lacking the
tetramerization domain, only slightly shortens the lag phase, whereas
the rate of self-association (ΔA′350/Δt) is almost the same as for the G46S-
hPAHdimeraloneor in thepresenceof a5-foldmolar excess of ovalbumin
(Fig. 7B). A dimericmutant form (T427P-hPAH),with a reduced tendency
to form tetramer [19], promotes a lower rate of self-association of the
G46S-hPAH dimer than the WT-hPAH dimer (Fig. 7B). Moreover, the
G46S-hPAH dimer in the presence of a 5-fold molar excess WT-hPAH
dimer and 1 mM L-Phe, displayed almost the same lag phase as for the
G46S-hPAH dimer alone and only a slightly increased ΔA′350/Δt value
(Fig. 7C). In this case the presence of L-Phe promotes the formation of
WT tetramer [17]. The presence of 1 mM L-Phe has a negligible effect on
the self-association pattern of the G46S-hPAH dimer alone (Fig. 7C)
indicating that the G46S dimer↔G46S tetramer equilibrium is less
responsive to L-Phe than that of WT-hPAH.
Fig. 6. Effect of phosphorylation at Ser16 and chaperones on the self-association of tetrameric G46S-hPAH. (A) The time-course for the self-association of phosphorylated enzyme
(▲) and non-phosphorylated enzyme (●). The non-phosphorylated fusion protein control was obtained by incubating the enzyme in the absence of added PKA catalytic subunit,
under otherwise identical conditions of the phosphorylated enzyme. Results are representative of two independent experiments. (B) The effect of Hsp70/Hsp40 (molar ratio 100:1)
on the self-association of G46S-hPAH at different concentrations (expressed as molar ratios of chaperone:G46S-hPAH fusion protein): 0:1 (●), 1:20 (▲), 1:10 (□), 1:5 (◊) and 1:2
(▼). (C) The effect of Hsp90 on the self-association of G46S-hPAH at different concentrations (expressed as molar ratios of chaperone:G46S-hPAH fusion protein): 0:1 (●), 1:20 (▲),
1:10 (□),1:5 (◊) and 1:2 (▼). (D) The effect of a pharmacological chaperone on the time-course of the self-association. The data points represent G46S-hPAH in the absence of any
added compound (●), in the presence of 0.83% DMSO (▲) or of 100 μM 3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-1,2-dihydroisoquinolin-1-one (in 0.83% DMSO) (■). The self-
association reactions were performed at standard assay conditions (0.74 mg ml−1 fusion protein (7.85 μMmonomer), 5.0 μg ml−1 factor Xa, 20 mM Na-Hepes, 0.1 M NaCl, pH 7.0
and 25 °C). Some data points were omitted for clarity. Error bars represent mean±SD, (n=3).
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Thioﬂavin-T (ThT) is a dye that when bound to amyloid ﬁbrils
displays an enhanced ﬂuorescence at 482 nm, but nonspeciﬁc binding
to some non-amyloid proteins has also been reported [23]. Binding of
ThT to MBP-WT-hPAH results in a ﬂuorescence enhancement (ΔThT)
beyond that of MBP alone, but did not signiﬁcantly increase (P=0.13)
upon cleavage by factor Xa (Fig. 8A). The MBP-G46S-hPAH fusion
protein revealed a signiﬁcantly higher ΔThT-value than MBP-WT-
hPAH (pb0.01), and factor Xa cleavage further increased the
ﬂuorescence enhancement (pb0.01). About 50% of the total ΔThT-
value (at 3 h) was observed during the lag period (~42 min) in which
no light scattering (and ﬁbril formation) was observed (Fig. 8B).
Moreover, during the period of exponential increase in light scattering
the ΔThT represented only 37% of the total ﬂuorescence response.
Thus, the ThT ﬂuorescence enhancement of G46S-hPAH vs the WT-
hPAH protein is dominated by the cleavage of the fusion protein and a
related conformational change.
ANS is a spectroscopic probe that has afﬁnity for hydrophobic
clusters which are not tightly packed in a fully folded structure, or
become exposed in partially unfolded structures [44]. ANS binds to
G46S-hPAH fusion protein (Fig. 8C, trace 5) with an increase in the
ﬂuorescence intensity and a maximum at ~478 nm (blue shift). Sincethis ﬂuorescence response is higher than that observed for the WT-
hPAH fusion protein (Fig. 8C, trace 3), the mutant form has more
hydrophobic clusters exposed than the WT-hPAH. However, after
cleavage the ﬂuorescence intensity of the mutant form G46S-hPAH
(Fig. 8C, trace 7) is only slightly higher than that of the fusion protein
(Fig. 8C, trace 5). TheMBP fusion partner has a negligible contribution to
the ANS ﬂuorescence (Fig. 8C, trace 2).
3.13. Self-association of the isolated regulatory domain
To further assess the importance of the R-domain for the self-
association of full-length G46S-hPAH, we generated WT and G46S
truncated forms including the N-terminal residues 2–120 (R-domain)
and examined their oligomeric state as MBP fusion proteins and
propensity to self-associate on factor Xa cleavage. On bacterial
expression as MBP fusion proteins and afﬁnity puriﬁcation the WT
form was recovered in high yield as a mixture of dimer and monomer
(Supplementary Fig. S3A),whereas the recovery of themutant formwas
very low with higher-order oligomers as the predominating species
(Supplementary Fig. S3B). Moreover, SDS-PAGE revealed that the
mutant form was signiﬁcantly more proteolysed than the WT form
(Supplementary Fig. S3A and B, inset). On cleavage of the dimeric fusion
proteins by factor Xa both proteins self-associate with a similar time-
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Fig. 7. The self-association of G46S-hPAH dimers and the effect of WT-hPAH dimers and L-Phe. (A) The time-course for the self-association of G46S-hPAH tetramers (●) and dimers
(▲) following cleavage of the respective fusion proteins by factor Xa. (Δ) G46S-hPAH dimer fusion protein in the absence of factor Xa. (B) The self-association of G46S-hPAH dimers
in the absence of any added protein (▲), and in the presence of a 5-fold molar excess (5×) ofWT-hPAH dimer (■), or of 5×ΔC24-hPAH dimer (∇), or of 5×T427P-hPAH dimer (♦) or
of 5×ovalbumin (○). (C) The effect of L-Phe on the self-association of G46S-hPAH dimers in the absence and presence of WT-hPAH dimers. G46S-hPAH dimers in the absence of any
added protein and L-Phe (▲) or with 1 mM L-Phe (Δ); G46S-hPAH dimers in the presence of a 5-fold molar excess of WT-hPAH dimers with no L-Phe (■) or with 1 mM L-Phe (□).
(D) Schematic presentation of the G46S-WT homo- and heterotetramer formation. The reactions in (A–C) were performed at standard assay conditions (0.74 mg ml−1 fusion
protein, 5.0 μg ml−1 factor Xa, 20 mM Na-Hepes, 0.1 M NaCl, pH 7.0 and 25 °C) and the WT-hPAH, ΔC24-hPAH and T427P-hPAH enzyme forms were added as already factor Xa
cleaved forms. Some data points were omitted for clarity. Error bars represent mean±SD, (n=3).
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light scattering (Fig. 8D). Self-association of the WT protein was
inhibited by both substrates (L-PheNBH4), whereas self-association of
the G46Smutant R-domain remained unaffected. In both conditions the
L-Phe substrate had no effect on the cleavage by factor Xa (Supplemen-
tary Fig. S3C and D). The formation of higher-order oligomers gave only
a minor enhancement of the ThT ﬂuorescence (Fig. 8A) and no ﬁbrils
were detected on EM (data not shown).3.14. Ultrastructure of G46S-hPAH polymers
In order to get information on the structure of the higher-order
oligomers that are formed after cleavage of the G46S-hPAH fusion
protein, negative staining EM was performed. For the WT-hPAH no
signiﬁcant difference was observed in the EM pattern when comparing
time points 0 and 180 min (data not shown). By contrast, the G46S-
hPAH(Fig. 9A–E) revealed a variety of higher-order structures in a time-
dependent fashion. At the end of the delay period small clusters of
higher-order oligomeric structures of tetrameric G46S-hPAH were
observed (Fig. 9B), followed in time by the appearance of linear
polymers (Fig. 9C) (correlating with increased light scattering). These
ﬁbrils can bundle together and form branches thereby formingextensive network structures (Fig. 9D). EM also revealed that some of
the longﬁbrils display an apparent twisted conﬁguration (Fig. 9E).Using
highmagniﬁcation images (insetof panel Fig. 9E and Supplementary Fig.
S4) the diameters of the ﬁbrils were determined as ~145 Å (the
narrowest region) and ~300 Å (the broadest region), using a correction
of 15% for the ﬂattening on the electron microscope grid [45].
Interestingly, dimeric G46S-hPAH also generates ﬁbrils with a pro-
nounced tendency to network formation (Fig. 9D), which is inhibited by
a 5-fold molar excess of WT-hPAH dimer (Fig. 9F). Additionally, the
pharmacological chaperone 3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-
1,2-dihydroisoquinolin-1-one inhibits the formation of ﬁbrils by
tetrameric G46S-hPAH (Fig. 9G).4. Discussion
4.1. Self-association of G46S-hPAH in vitro
The isolated tetrameric/dimeric MBP-(pep)Xa-G46S-hPAH fusion
protein is recovered in a soluble metastable form, stabilized by MBP
as a chaperone. When cleaved by the restriction protease factor Xa
the released free enzyme is destabilized and forms different types of
higher-order oligomers and polymers (ﬁbrils), as determined by
Fig. 8. The binding of thioﬂavin-T (ThT) and ANS. The binding of ThT and ANS to the uncleaved and cleaved MBP fusion proteins of truncated (residues 2–120, R-domain) and full-
length forms of WT and G46S mutant hPAH. (A) ThT ﬂuorescence enhancement (ΔThT) was measured on samples at the beginning of the cleavage reaction of the respective fusion
proteins by factor Xa and at the end point (t=3 h). The response was normalized by subtracting the background ﬂuorescence of ThT and light scattering contribution, and the values
represent means±SD of three independent experiments (*Pb0.01, **P=0.13). (B) Time-course of the ThT ﬂuorescence enhancement following cleavage of the MBP-G46S-hPAH,
including the lag phase (~42 min) and the exponential self-association (78 min), as measured by light scattering and EM (78 min). The start and maximum of light scattering from
Fig. 4B is indicated, as well as the change in ThT ﬂuorescence (ΔThT) at selected time points, with the percentage of cleavage speciﬁed (Fig. 4A). (C) ANS ﬂuorescence emission
spectra observed during the cleavage of MBP-G46S-hPAH fusion protein by factor Xa, i.e. at t=0min (trace 5), at t~42 min (trace 6) and at t=3 h (trace 7). The corresponding
spectra for the cleavage of MBP-WT-hPAH fusion protein are shown for comparison at t=0min (trace 3) and t=3 h (trace 4). The MBP protein was used as a control (trace 2) and
the emission spectrum of buffer with ANS is shown (trace 1). The excitation wavelength was 385 nm. (D) The self-association of a truncated form (residues 2–120, R-domain) ofWT-
hPAH and its G46S mutant form and the effect of the substrate (L-Phe). The time-course of the self-association of WT-hPAH (2–120) dimeric protein following cleavage of the fusion
protein by factor Xa in the absence (●) and presence of 150 μM L-Phe (○); G46S-hPAH (2–120) dimer fusion protein following cleavage by factor Xa in the absence (▼) and presence
of 150 μM L-Phe (∇). The assays were performed at standard assay conditions and error bars represent mean±SD, n=3 independent experiments.
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formation of polymers involves at least three elementary processes:
(i) the cleavage of the fusion protein with release of the free enzyme
tetramer/dimer,
MBP−ðpepÞXa−G46S−hPAH
↓ Factor Xa
G46S−hPAH + MBP
ð1Þ
and (ii) self-association with the formation of higher-order oligo-
mers/short polymers [(G46S-hPAH)n], detectable by EM (Fig. 9B) and
to some extent by light scattering at 350 nm,
n⋅G46S−hPAH
↓
ðG46S−hPAHÞn
ð2Þand (iii) the autocatalytic formation of larger structures [(G46S-
hPAH)m·n], detectable by light scattering and EM (Fig. 9C and E),
m⋅ðG46S−hPAHÞn
↓
ðG46S−hPAHÞm⋅n
ð3Þ
On cleavage, the light-scattering versus time proﬁle (Fig. 4B) can
be divided into a delay period (lag phase) and a growth phase with an
autocatalytic formation of higher-order oligomers/polymers that is
expressed as ΔA′350/Δt in the relatively linear part of the light
scattering increase. At the end point a decrease in light scattering was
observed at acidic pH, low ionic strength and temperature N15 °C,
caused by the sedimentation of protein at 1 g. By comparing the time-
course for the cleavage (Fig. 4A)with the delay time (Fig. 4B), it can be
concluded that the cleavage is not rate-limiting in the overall reaction
leading to the formation of hPAH polymers, most clearly seen at a low
temperature (Supplementary Fig. S1B and Table 2). The delay time
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neutral salt ionic strength and temperature (Fig. 5 and Table 2).
Moreover, the experimental conditions which favor a short delay time
also promote a high rate of the autocatalytic process.
4.2. The effects of chaperones
Since the ﬁrst report on PKU patients responding to oral administra-
tion of BH4 by lowering their blood Phe levels [46], the cofactor has been
successfully used for the long-term treatment of HPA patients as an
alternative to dietary treatment [47,48]. Basedon theBIOPKUdbdatabase
(www.bh4.org/BH4DatabasesBiopku.asp) [48] BH4-responsiveness is
expected in about 50% of all patients with PAH deﬁciency [48].
Interestingly, the responsive mutations are preferentially located to the
R-domain, possibly related to its structural and physico-chemical
properties (see below), and the effect on its stability by the speciﬁc
interaction with the 1′,2′-dihydroxypropyl side-chain of BH4, when
bound at the active site of WT-hPAH [16,37]. A positive clinical response
to BH4 has been reported even in a patient with severe PKU and the
genotype G46S/S303A [47], but it was concluded that the S303A allele
was responsible for the observed decrease in plasma Phe level caused by
oral BH4. The present in vitro study (Table 2) further supports the
conclusion that the G46S allele is non-responsive to BH4.
Due to the mutant selectivity and the high cost of BH4 alternative
pharmacological chaperones have been explored. A recent screening of
over 1000 pharmacological agents has identiﬁed a small-molecule
binder (3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-1,2-dihydroisoqui-
nolin-1-one) that efﬁciently enhances the thermal stability of WT-
PAH andmisfoldedmutant forms in the R-domain (I65T and R68S), and
signiﬁcantly increases the activity and steady-state PAHprotein levels in
transiently transfected cells [41]. Here we have found that this small-
molecule binder, used at a comparable concentration (100 μM), partly
inhibits the self-association of G46S-hPAH, as measured by light
scattering (Fig. 6D) and completely inhibits the ﬁbril formation
(Fig. 9G).
Glycerol and trimethylamine N-oxide (TMAO) have been shown to
correct folding/assembly defects of some neurodegenerative and
metabolic conformational disorders [49–53]. In this study glycerol had
a protective effect, with a delayed lag phase and decreased ΔA′350/Δt
value, whereas TMAOpromoted the self-association (Table 2). A similar
promotive effect was observed for (−)-epigallocatechin gallate (EGCG)
(Table 2), themajor polyphenol in green tea thatwas recently shown to
inhibit the ﬁbrillogenesis of amyloidogenic polypeptides [54].
4.3. The self-association of G46S-hPAH generates non-amyloid ﬁbrils
With reference to the ThT ﬂuorescence response (Fig. 8A and B) and
the ultrastructures observedby EM (Fig. 9), three lines of evidence point
to the formation of non-amyloid ﬁbrils. First, in the self-association of
G46S-hPAH the initial part (~51%) of the hyperbolic time-course for ThT
ﬂuorescence enhancement occurs in the lag phase (~42 min) where no
increase in light scattering or formation of ﬁbrils was observed. In the
self-association of proteins forming amyloid-like ﬁbrils the ThT
ﬂuorescence enhancement is related to the ﬁbril formation [55]. Thus,
the initial ﬂuorescence enhancement of G46S-hPAH is related to the
main cleavage of the fusion protein (~89%), presumably reﬂecting a
conformational change in its R-domain, since no ﬂuorescence enhance-
ment was observed on cleavage of the WT-hPAH fusion protein
(Fig. 8A). Such unspeciﬁc binding of ThT has been observed for someFig. 9. Electron micrographs of negatively stained G46S-hPAH before and after cleavage of i
before cleavage, and (B) after cleavage for 42 min (~ the end of lag phase, as shown in Fig. 4B)
the dimeric MBP-G46S-hPAH in the absence (D) and presence of a 5-fold molar excess of di
(inset) at high resolution. (G) The effect of the pharmacological chaperone 3-amino-2-b
tetrameric G46S-hPAH at t=3 h of cleavage. The proteins were negatively stained with aqu
Short ﬁbrils in B and F are indicated by arrows. Scale bars: 500 nm (A–C, F and G), 1 μm (Dother proteins [23,55]. In addition, studies on amyloid-like peptides
revealed apoor correlationbetweenThTﬂuorescence enhancement and
the formation of amyloid-like structures [56]. Secondly, the ΔThT value
increased by only 37% during the autocatalytic formation of ﬁbrils
(Fig. 8B), partly explained by the residual cleavage of the fusion protein.
Thirdly, the ﬁbrils generated by G46S-hPAH are highly branched (Fig. 9
and Supplementary Fig. S4A) forming networks, and the diameters of
individual ﬁbrils range from ~145 to 300 Å, whereas amyloid and
amyloid-likeﬁbrils appear byEMas rigid, nonbranching structures from
~60 to 130 Å in diameter [57].
The self-association of G46S-hPAH demonstrates some apparent
similarities with that of sickle cell hemoglobin (deoxy-HbS). Deoxy-
HbS and G46S-hPAH are bothmisfolded tetrameric proteins, and their
self-association is caused by mutations affecting a single surface
exposed amino acid (E6V in the β-chain of HbS and G46S in the R-
domain of hPAH). The twomutant proteins also display similar kinetic
patterns of the self-association process, as measured by light
scattering, and they polymerize into a number of ultrastructures as
a function of time, initiated by factor Xa cleavage of MBP-G46S-hPAH
and by deoxygenation of HbS, respectively [58]. The G46S-hPAH ﬁbrils
and those derived from deoxy-HbS also share common properties. At
the present resolution (160,000×) the typical ﬁbrillar structures
formed by tetrameric G46S-hPAH (Fig. 9E, inset and Supplementary
Fig. S4A) show the above described periodic variation in apparent
diameter, i.e. from ~145 Å (the narrowest region) to ~300 Å (the
broadest region). Some of the structures have the appearance of
twisted ﬁbrils (Fig. 9C and Supplementary Fig. S4A). By comparison,
the corresponding dimensions of the deoxy-HbS ﬁbrils were reported
to be 180 and 230 Å [45,59]. However, the self-association of the two
proteins involves different molecular mechanisms.
4.4. Structural insight into the self-association of G46S-hPAH
InWT-PAH the R-domain has some unique structural and physico-
chemical properties, which may explain why mutations in this
domain affect the stability of the enzyme. First, the 3D structure [34]
has demonstrated an overall high crystallographic B-factor of the R-
domain (Fig. 2B). In the full-length enzyme the R-domain is also
characterized by a particularly low thermal stability, as compared to
the C-domain [60,61]. The R-domain is partly stabilized by its
interaction with the 1′,2′-dihydroxypropyl side-chain of the pterin
cofactor BH4 when bound at the active site [16,37]. Secondly, by using
the TANGO algorithm for sequence-dependent prediction of the
propensity to aggregate [62], the β1-strand (residues I35–L41) and
the β2-strand (residues E76–T81) were predicted to promote
aggregation, whereas the G46S substitution did not change this
prediction. However, since the WT-hPAH tetramer/dimer, in contrast
to the G46S-hPAH tetramer/dimer, does not self-associate at standard
experimental conditions (Fig. 4B), the predicted aggregation propen-
sity cannot explain the difference. Of more importance is the
prediction (Fig. 2C) that the G46S mutation results in an extension
of α-helix 1 by four residues. Such a change of the Cα backbone
conformation and the α–β sandwich structure of theWT enzymemay
promote new intermolecular contacts and self-association via the
mutually misfolded regions of their R-domains (Supplementary Fig.
S4B). Thirdly, the inhibitory effect of phosphorylation of Ser16
(Fig. 6A) also indicates that the Cα backbone conformation of the R-
domain is important for the self-association process. Moreover, MD
simulations of WT-hPAH have revealed that this phosphorylationts MBP fusion protein by factor Xa. (A) The tetrameric MBP-G46S-hPAH fusion protein
, and (C) for 2 h (~maximum light scattering, Fig. 4B). (D and F) The result of cleavage of
meric WT-hPAH (F). (E) The twisted ﬁbrils and a single ﬁbril of tetrameric G46S-hPAH
enzyl-7-nitro-4-(2-quinolyl)-1,2-dihydroisoquinolin-1-one on the self-association of
eous uranyl acetate and analyzed in Jeol 1230 Electron Microscope operated at 80 kV.
) and 100 nm (E).
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(residues 1–33) [16], and FT-IR spectroscopy of the isolated WT R-
domain (residues 2–110) has suggested that it induces an apparent
increase in the α-helix content [15]. In addition, deamidation of labile
asparagine residues in hPAH— notably Asn32 in the R-domain [63] —
also affects the G46S-hPAH self-association. Accordingly, the non-
deamidated form of G46S-hPAH (2 h induction) showed a higher
tendency to self-associate (with a slightly shorter lag phase and a
higher rate of self-association), as compared with the deamidated
G46S-hPAH form (24 h induction) (Supplementary Fig. S5). Studies
on the isolated R-domain (residues 2–120) (Fig. 8D) further
emphasize the importance of its conformation in the self-association
process. The dimeric and monomeric forms of this truncated protein
display a high propensity to self-associate, even in their WT forms,
and the G46S mutation slightly increased this propensity.
The ﬁnding that the G46S-hPAH dimer also self-associates beyond
the tetrameric state, although at a slower rate than the tetramer
(Fig. 7A), requires a special comment. Since theWT-PAH exists in a two-
state TM↔DM equilibrium [8], it is likely that a similar equilibrium
exists for theG46S-hPAHmutant. As seen from Fig. 7B, the presence of a
superstoichiometric amount of WT dimer during the cleavage of the
MBP-G46S-hPAH dimer supports the formation of hybrid WT–G46S
heterotetramer, which self-associates at an enhanced rate compared to
G46S-hPAH dimer alone. In this case, however, EM studies demonstrat-
ed predominantly amorphous aggregates (Figs. 7D and 9F). Based on
these results one might expect that in a heterozygous WT/G46S
genotype, the fraction of the G46S-hPAH dimer could form WT–G46S
heterotetramers that would promote the self-association and the
degradation of the WT subunit. However, in WT-hPAH the TM↔DM
equilibrium is shifted towards the tetrameric form in the presence of L-
Phe [17], whereas in G46S-hPAH the TM↔DM equilibrium is less
responsive to L-Phe, as there is only a minor enhancement of the self-
association of the G46S-hPAH dimer in the presence of 1 mM L-Phe
(Fig. 7C). Because the two equilibria respond differently to L-Phe, the
WT-hPAH dimer will formWT-hPAH tetramers in the presence of L-Phe
and will not be available to form WT–G46S heterotetramers that were
responsible for the observed enhancement of the self-association of the
G46S-hPAH dimer in the presence of the WT-hPAH dimer. The
concentration of L-Phe (50–100 μM in the hepatocyte of normal
individuals), depends on the metabolic state and extracellular concen-
tration of L-Phe in the blood [64]. In a homozygous G46S phenotype the
L-Phe will not have any signiﬁcant effect on the TM↔DM equilibrium
(Fig. 7C). Thus, our results suggest that the self-association of G46S-
hPAH is favored by the tetrameric structure, and the propensity of the
G46S-WT hybrids to self-associate is deﬁned by the conformational
state of the G46S subunits.
The relation between self-association of a protein, its fundamental
physico-chemical intrinsic properties (e.g. hydrophobicity, secondary
structure propensity, charge and hydrophobic/ hydrophilic patterns),
and extrinsic factors have been extensively studied [65–67]. All the
data presented in this study (pH, ionic strength, phosphorylation state
of Ser16) indicate that the net charge of the protein, or its R-domain, is
a main modulator of the self-association of G46S-hPAH in vitro, as
measured by light scattering (Table 2).
4.5. Potential in vivo implications
In our previous transfection studies in HEK293 cells the expression
level of G46S-hPAH was only ~3% of WT-hPAH (immunoreactive PAH
protein) when related to the mRNA levels, compatible with the severe
form of PKU observed in the homozygous patient [12]. The present in
vitro studies offer an explanation for the accelerated degradation of the
mutant protein, although we do not know how G46S self-associates in
the complex and crowded macromolecular environment of the
hepatocyte. Since there is no reported link between any liver
dysfunction or amyloid pathology and severe forms of PKU, it is unlikelythat self-associated,misfoldedhPAHmutant proteins exert a toxic effect
on the liver. Based on inhibition of the self-association of tetrameric
G46S-hPAH in vitro by substoichiometric concentrations of the heat-
shock protein Hsp90 (Fig. 6C), and to some extent by Hsp70/Hsp40
(Fig. 6B), themutant is a likely client protein of themolecular chaperone
systems in vivo, as observed for the chaperonins GroESL on co-
expression with several PKU/HPA mutant proteins in E. coli [5,68,69].
However, the accelerated degradation of G46S-hPAH in HEK293 cells
[12] indicates that the physiological level of chaperones in these cells
(and in hepatocytes) is not sufﬁcient to rescue this misfolded protein.
Therefore, the main question to be answered relates to the mechanism
bywhichG46S-hPAHand relatedmisfoldedandunstable hPAHproteins
are degraded in vivo. AlthoughWT-hPAH is poly/multi-ubiquitinated in
vitro [70], no signiﬁcant stabilizing effect of proteasome inhibitors have
been observed in cases of selected missense mutations [4]. Therefore,
the accelerated turnover observed upon their expression in eukaryotic
cells may be explained by an alternative quality control mechanism.
Previous studies on the turnover of WT-hPAH in cultured hepatoma
cells gave an estimated half-life of 8.2 h [71], i.e. similar to that of a
number of other cytosolic liver proteinswith a slow turnover, which are
considered to be degraded by autophagosome pathway [72]. Intracel-
lular self-association of a number of misfolded proteins has been
connected with the formation of aggresomes, which are ultimately
degraded by autophagolysosomes, in a process that also involves
ubiquitination [73].
4.6. Relevance for the study of misfolding PKU/HPA mutations
The tetrameric form of recombinant WT-hPAH has a small margin
of stability. Even a low concentration of a mild denaturant (urea)
allows the enzyme to explore a range of different structural states and
induces its self-association [74]. Therefore, it is not unexpected to ﬁnd
a high frequency of misfolding hPAH mutations associated with PKU/
HPA, resulting in a variety of molecular subtypes showing different
conformational and stability properties. Thus, these misfolded hPAH
proteins represent a phenotypically heterogeneous groupwhich often
has a propensity to self-associate and to form higher-order oligomers
when overexpressed in prokaryotic systems, and are rapidly degraded
when expressed in eukaryotic cells. Upon overexpression in E. coli,
these misfolded mutant proteins are often stabilized by MBP as a
fusion partner, and the metastable fusion proteins are frequently used
in in vitro studies to elucidate the molecular basis of the functional
impairment in PAH deﬁciency [9,68,69]. However, the present study
shows that the physico-chemical properties of the metastable MBP-
mutant-hPAH fusion protein are not representative for those of the
mutant protein. Our current experimental approach, therefore, should
be a useful supplement in systematic in vitro studies of misfolded
PAH/HPA-associated mutant proteins, as well as for the assessment of
the capability of molecular and pharmacological chaperones to
prevent their self-association and stabilize their native states. This
experimental approach may also provide valuable mechanistic
insights into the frequently observed and poorly understood
compound heterozygous forms of PKU/HPA [75].
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